Brief: Divi's Labs Says Us-FDA Inspection Of Co's Unit-II Manufacturing Facility At Andhra Pradesh
July 19 (Reuters) - Divi's Laboratories Ltd DIVI.NS :
* DIVI'S LABS - US-FDA INSPECTION OF COMPANY'S UNIT-II
MANUFACTURING FACILITY AT ANDHRA PRADESH
* DIVI'S LABS - US-FDA INSPECTION IS SUCCESSFULLY COMPLETED
WITH
ONE PROCEDURAL OBSERVATION
Source text for Eikon: ID:
Further company coverage: DIVI.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Divi's Laboratories
See all newsDivi's Laboratories and Laurus Labs lead India's record CRDMO growth, Jefferies says
India Stocks: Indian shares inch higher to close at 8-month high as crude oil drops
India's Divi's Laboratories jumps to record high after profit jumps by nearly two thirds
Indian shares muted as markets pause after last week's rally
India Stocks: Indian shares consolidate in Diwali session after seven-day rally